DAVID M WOJCIECHOWSKI
Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology DALLAS, TX NPI 1013976844
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology TX E.R. Squibb & Sons, L.L.C. All categories
General Payments — all program years on this page
$22,147.67
- Category: General Payments
- Program years: PY2018–2023
- Record count: 41
- As of (CMS publication): 2026-01-23
Latest program year (PY2023): $3,742.59 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2023) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $3,341.25 | 1 |
| Food and Beverage | $225.53 | 6 |
| Travel and Lodging | $175.81 | 1 |
By paying entity
Latest program year (PY2023) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $3,683.22 | 6 |
| Horizon Pharma plc | $35.34 | 1 |
| Acerta Pharma LLC | $24.03 | 1 |
By program year
Records — PY2023 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1014201681 | AstraZeneca Pharmaceuticals LP | $24.03 | 08/14/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015529897 | E.R. Squibb & Sons, L.L.C. | $175.81 | 12/08/2023 | Travel and Lodging | Undisputed | 01/23/2026 | View at CMS |
| 1015529901 | E.R. Squibb & Sons, L.L.C. | $3,341.25 | 12/11/2023 | Consulting Fee | Undisputed | 01/23/2026 | View at CMS |
| 1015529917 | E.R. Squibb & Sons, L.L.C. | $50.00 | 12/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015529921 | E.R. Squibb & Sons, L.L.C. | $25.70 | 12/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015529925 | E.R. Squibb & Sons, L.L.C. | $61.91 | 12/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1015529929 | E.R. Squibb & Sons, L.L.C. | $28.55 | 12/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 987090901 | Horizon Therapeutics plc | $35.34 | 06/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.